The calcium/calmodulin-dependent protein kinase II (CaMKII) and mitogen-activated protein kinase (MAPK) pathways are two of the major cellular signalling pathways that drive cardiac hypertrophy. This evidence concerns the gene CAMK2G and cardiac hypertrophy.